Literature DB >> 3029952

The amino terminus of the bacteriophage D108 transposase protein contains a two-component sequence-specific DNA-binding domain.

P P Tolias, M S Dubow.   

Abstract

We have cloned various amino-terminal domains of the transposable bacteriophage D108 A protein (transposase) into a high-copy-number expression vector and visualized the D108 polypeptides and fusion proteins expressed by the recombinant plasmids. By using crude protein extracts made from strains harboring these recombinant plasmids, we have performed band competition assays and DNasel footprinting on a 32P-end-labeled DNA restriction fragment which contained the Mu right end (to which the Mu A protein binds) and have shown that these fusion proteins in crude extracts can specifically bind to this DNA substrate. Furthermore, we have divided the amino-terminal 13 kDa of the D108 A protein (which may contain two bi-alpha-helical protein structures) in half and have shown that each half is capable of independent binding to the Mu attR site. These results suggest that the D108 transposase protein contains multiple DNA-binding domains which may be required for the complex protein-DNA interactions of D108 transposition.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029952     DOI: 10.1016/0042-6822(87)90320-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  3 in total

1.  Construction of stable, single-copy luciferase gene fusions in Escherichia coli.

Authors:  A Guzzo; M S DuBow
Journal:  Arch Microbiol       Date:  1991       Impact factor: 2.552

2.  The cis-acting DNA sequences required in vivo for bacteriophage Mu helper-mediated transposition and packaging.

Authors:  J Harel; L Duplessis; J S Kahn; M S DuBow
Journal:  Arch Microbiol       Date:  1990       Impact factor: 2.552

3.  Transcription of the Escherichia coli fliC gene is regulated by metal ions.

Authors:  A Guzzo; C Diorio; M S DuBow
Journal:  Appl Environ Microbiol       Date:  1991-08       Impact factor: 4.792

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.